Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
Tarantino, Michael D; Bussel, James B; Blanchette, Victor S; Despotovic, Jenny; Bennett, Carolyn; Raj, Ashok; Williams, Bronwyn; Beam, Donald; Morales, Jaime; Rose, Melissa J; Carpenter, Nancy; Nie, Kun; Eisen, Melissa.
; 388(10039): 45-54, 2016 Jul 02.
Artigo em Inglês | MEDLINE | ID: mdl-27103127
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists.
Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.
Clinical updates in adult immune thrombocytopenia.
Positioning new treatments in the management of immune thrombocytopenia.
State of the art - how I manage immune thrombocytopenia.
How we manage immune thrombocytopenia in the elderly.
Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia.
[Treatment of Idiopathic Thrombocytopenic Purpura by Xiaoban Decoction: a Case Observation of 119 Patients].
Current topics in primary immune thrombocytopenia.